East Coast Asset Management, Llc. Amgen Inc Transaction History

East Coast Asset Management, Llc.

$241 Million
Q1 2025

A detailed history of East Coast Asset Management, Llc. transactions in Amgen Inc stock. As of the latest transaction made, East Coast Asset Management, Llc. holds 1,628 shares of AMGN stock, worth $453,235. This represents 0.21% of its overall portfolio holdings.

Number of Shares

1,628

Previous 1,950 16.51%

Holding current value

$453,235

Previous $508,000 0.2%

% of portfolio

0.21%

Previous 0.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$258.59 - $327.36 $83,265 - $105,409	-322 Reduced 16.51%	1,628 $507,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $8,066 - $9,450	-38 Reduced 1.91%	1,950 $415,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $8,876 - $9,847	38 Added 1.95%	1,988 $485,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $67,848 - $83,259	-343 Reduced 14.96%	1,950 $460,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $41,915 - $55,591	-230 Reduced 9.12%	2,293 $465,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $62,250 - $80,012	-329 Reduced 11.54%	2,523 $608,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $46,676 - $54,714	-280 Reduced 8.94%	2,852 $526,000
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $516,083 - $579,673	-3,108 Reduced 49.81%	3,132 $578,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $454,977 - $511,037	2,740 Added 78.29%	6,240 $654,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $121,989 - $142,560	-720 Reduced 17.06%	3,500 $597,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $32,070 - $35,832	190 Added 4.71%	4,220 $734,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $674,178 - $769,730	4,030	4,030 $751,000

Others Institutions Holding AMGN

# of Institutions

3,308

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of East Coast Asset Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on East Coast Asset Management, Llc. with notifications on news.

Account

East Coast Asset Management, Llc. Amgen Inc Transaction History